Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Constellation Brands, Inc of Class Action Lawsuit and Upcoming Deadlines - STZ
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Newmont Corporation of Class Action Lawsuit and Upcoming Deadlines – NEM
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FMC Corporation of Class Action Lawsuit and Upcoming Deadlines - FMC
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ICON Public Limited Company of Class Action Lawsuit and Upcoming Deadlines - ICLR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mullen Automotive, Inc. of Class Action Lawsuit and Upcoming Deadlines - MULN
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TELUS International (Cda) Inc. of Class Action Lawsuit and Upcoming Deadlines - TIXT
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Polestar Automotive Holding UK PLC of Class Action Lawsuit and Upcoming Deadlines - PSNY
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Grocery Outlet Holding Corp of Class Action Lawsuit and Upcoming Deadlines - GO
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Monolithic Power Systems, Inc. of Class Action Lawsuit and Upcoming Deadlines - MPWR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines – MRK
-
Vertex Commerce Study: Returnuary’s Growing Complexity Forces Retailers to Keep Pace
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Arconic Corporation. of Class Action Lawsuit and Upcoming Deadlines – ARNC
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ModivCare, Inc. of Class Action Lawsuit and Upcoming Deadlines – MODV
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Alarum Technologies Ltd. and Certain Officers – ALAR
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Integral Ad Science Holding Corp. – IAS
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Quantum Computing Inc. and Certain Officers – QUBT
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against e.l.f. Beauty, Inc. and Certain Officers – ELF
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers – WBA
-
Aligos Therapeutics Presents Positive Data at APASL 2025
-
BIO-key Completes Initial Biometric-Based Identity and Access Management Deployment for New International Defense Agency Customer in Record Time
-
Fixing of Coupon Interest Rate
-
HydroGraph Announces April Investor Relations and Conference Schedule
-
Codego Launches CDG: New Plug-and-Play Devices for Effortless Daily Passive Income
-
Bitget Maintains 213% Reserve Ratio in March 2025 Proof-of-Reserves Update
-
ELI Launches Innovative Learning System to Prevent Workplace Incivility and Improve Results
-
Saudi National Pavilion at London Design Biennale 2025: "Good Water" Invites us to Rethink Our Relationship With Water
-
Saudi National Pavilion at London Design Biennale 2025: "Good Water" Invites us to Rethink Our Relationship With Water
-
Alliance Witan PLC - Net Asset Value
-
Majority of General Counsel Indicate Openness to Using AI in Nearly Every Major Legal Use Case, According to The General Counsel Report
-
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
-
Purpose Investments Inc. Announces Final March 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico
-
Entourage Health Increases Senior Secured Credit Facility
-
VR Resources Reports Drilling Results at Silverback Copper-Gold Project in Northwest Ontario
-
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
-
Mawson Infrastructure Group Inc. Executes New Customer Agreement with Canaan Inc., Growing and Expanding Digital Colocation Business with Latest-Gen ASICs
-
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiom
-
Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting
-
Prime Drink Group Announces Closing of $1.8 Million Private Placement
-
SEALSQ’s QS7001 Secure Chip to Quantum-Proof Blockchain Platforms
-
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
-
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
-
Digi Power X to Announce 2024 Year End Financial Results on March 31st
-
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors
-
Madis Toomsalu expresses will to resign as CEO of LHV Group
